Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The atypical receptor CCRL2 is essential for lung cancer immune surveillance.

Del Prete A, Sozio F, Schioppa T, Ponzetta A, Vermi W, Calza S, Bugatti M, Salvi V, Bernardini G, Benvenuti F, Vecchi A, Bottazzi B, Mantovani A, Sozzani S.

Cancer Immunol Res. 2019 Sep 4. pii: canimm.0168.2019. doi: 10.1158/2326-6066.CIR-19-0168. [Epub ahead of print]

PMID:
31484658
2.

Chemokine and chemotactic signals in dendritic cell migration.

Tiberio L, Del Prete A, Schioppa T, Sozio F, Bosisio D, Sozzani S.

Cell Mol Immunol. 2018 Apr;15(4):346-352. doi: 10.1038/s41423-018-0005-3. Epub 2018 Mar 21. Review.

3.

Leukocyte trafficking in tumor microenvironment.

Del Prete A, Schioppa T, Tiberio L, Stabile H, Sozzani S.

Curr Opin Pharmacol. 2017 Aug;35:40-47. doi: 10.1016/j.coph.2017.05.004. Epub 2017 May 31. Review.

PMID:
28577499
4.

A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer.

Berlato C, Khan MN, Schioppa T, Thompson R, Maniati E, Montfort A, Jangani M, Canosa M, Kulbe H, Hagemann UB, Duncan AR, Fletcher L, Wilkinson RW, Powles T, Quezada SA, Balkwill FR.

J Clin Invest. 2017 Mar 1;127(3):801-813. doi: 10.1172/JCI82976. Epub 2017 Jan 30.

5.

A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment.

Kulbe H, Chakravarty P, Leinster DA, Charles KA, Kwong J, Thompson RG, Coward JI, Schioppa T, Robinson SC, Gallagher WM, Galletta L; Australian Ovarian Cancer Study Group, Salako MA, Smyth JF, Hagemann T, Brennan DJ, Bowtell DD, Balkwill FR.

Cancer Res. 2012 Jan 1;72(1):66-75. doi: 10.1158/0008-5472.CAN-11-2178. Epub 2011 Nov 7.

6.

Interleukin-6 as a therapeutic target in human ovarian cancer.

Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirström K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR.

Clin Cancer Res. 2011 Sep 15;17(18):6083-96. doi: 10.1158/1078-0432.CCR-11-0945. Epub 2011 Jul 27.

7.

B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis.

Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S, Mauri C, Coussens LM, Balkwill FR.

Proc Natl Acad Sci U S A. 2011 Jun 28;108(26):10662-7. doi: 10.1073/pnas.1100994108. Epub 2011 Jun 13.

8.

Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.

Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP, Bangham CR.

J Immunol. 2010 Jul 1;185(1):183-9. doi: 10.4049/jimmunol.0903846. Epub 2010 Jun 4.

9.

Divergent effects of hypoxia on dendritic cell functions.

Mancino A, Schioppa T, Larghi P, Pasqualini F, Nebuloni M, Chen IH, Sozzani S, Austyn JM, Mantovani A, Sica A.

Blood. 2008 Nov 1;112(9):3723-34. doi: 10.1182/blood-2008-02-142091. Epub 2008 Aug 11.

10.

p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A.

Cancer Res. 2006 Dec 1;66(23):11432-40.

11.

Role of tumor-associated macrophages in tumor progression and invasion.

Mantovani A, Schioppa T, Porta C, Allavena P, Sica A.

Cancer Metastasis Rev. 2006 Sep;25(3):315-22. Review.

PMID:
16967326
12.

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

Sica A, Schioppa T, Mantovani A, Allavena P.

Eur J Cancer. 2006 Apr;42(6):717-27. Epub 2006 Mar 7. Review.

PMID:
16520032
13.

A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Biswas SK, Gangi L, Paul S, Schioppa T, Saccani A, Sironi M, Bottazzi B, Doni A, Vincenzo B, Pasqualini F, Vago L, Nebuloni M, Mantovani A, Sica A.

Blood. 2006 Mar 1;107(5):2112-22. Epub 2005 Nov 3.

14.

Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Mantovani A, Sozzani S, Locati M, Schioppa T, Saccani A, Allavena P, Sica A.

Novartis Found Symp. 2004;256:137-45; discussion 146-8, 259-69. Review.

PMID:
15027487
15.

Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations.

Mantovani A, Schioppa T, Biswas SK, Marchesi F, Allavena P, Sica A.

Tumori. 2003 Sep-Oct;89(5):459-68. Review.

PMID:
14870765
16.

Regulation of the chemokine receptor CXCR4 by hypoxia.

Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo G, Sica A.

J Exp Med. 2003 Nov 3;198(9):1391-402.

17.

The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses.

Locati M, Otero K, Schioppa T, Signorelli P, Perrier P, Baviera S, Sozzani S, Mantovani A.

Allergy. 2002 Nov;57(11):972-82. Review. No abstract available.

PMID:
12358993

Supplemental Content

Loading ...
Support Center